X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

MOLECULAR PHARMACEUTICS

期刊標題檢索 Mol. Pharmaceut 最新評論: Successfully accepted, with one major revision and one minor revision,... (2024-10-18)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[MOLECULAR PHARMACEUTICS]您好,您是該頁面的第 162971 位訪客。

期刊簡介
期刊名稱MOLECULAR PHARMACEUTICS MOLECULAR PHARMACEUTICS
LetPub Score
7.8
50 ratings
Rate

Reputation
8.7

Influence
6.8

Speed
9.3

期刊簡稱Mol. Pharmaceutics
ISSN1543-8384
E-ISSN1543-8392
h-index110
CiteScore
CiteScoreSJRSNIPCiteScore Rank
8.000.9400.981
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q131 / 183
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Drug Discovery
Q136 / 157
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Molecular Medicine
Q251 / 178

自引率 (2023-2024)6.70%自引率趨勢
掲載範囲
Molecular Pharmaceutics publishes original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. Modalities of interest include small molecules, imaging agents, proteins, peptides, vaccines, cell and gene-based therapies, and their characterization, formulation, and delivery. Scientific areas within the scope of the journal include:

Modelling and simulation to aid mechanistic insights into drug delivery
Molecular understanding of formulations
Formulation performance under physiological conditions
Materials science as it relates to drug, excipients and drug delivery system efficacy.
Emerging techniques and technologies for drug delivery including theranostics, precision medicine and artificial intelligence
Theoretical and experimental peer-reviewed full-length research papers, critical reviews, perspectives, and communications are welcomed. Submission of a manuscript to Molecular Pharmaceutics implies that the same work has not been previously published, including as part of a public electronic database (preprint servers like bioRxiv and ChemRxiv are permissible), and is not under consideration for publication elsewhere. In addition, there must be no legal restrictions to publication, e.g., patent activities, at the time of submission.
官方網站https://pubs.acs.org/journal/mpohbp
在線稿件提交https://acs.manuscriptcentral.com/acs
開放訪問No
出版商American Chemical Society
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年2004
每年文章數460每年文章數趨勢
黃金OA百分比12.79%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ252/189
PHARMACOLOGY & PHARMACYSCIEQ160/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1543-8384%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 2.0 month(s)
競爭力 *來自作者的數據: About 50%
參考鏈接
相關期刊 【MOLECULAR PHARMACEUTICS】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498652
    PHYTOMEDICINE343677
    LIFE SCIENCES289700
    PHARMACOLOGICAL RESEARCH243344
    International Journal of Pharmaceutics242738
    European Journal of Pharmacology204538
    BIOCHEMICAL PHARMACOLOGY203049
    JOURNAL OF NATURAL PRODUCTS196859
    BRITISH JOURNAL OF PHARMACOLOGY165425
    DRUG DELIVERY162142
  •  

    MOLECULAR PHARMACEUTICS MOLECULAR PHARMACEUTICS
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)
  [MOLECULAR PHARMACEUTICS] 的評論撰寫評論
作者: xuesejieran


領域: 生物学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2024-10-18 20:17:26 評論於
Successfully accepted, with one major revision and one minor revision, the minor revision mainly focusing on formatting issues. Personally, I prefer ACS, and this journal seems fine as well. The impact factor has slightly decreased in the past two years, but it should increase next year. If the research is innovative, it is worth a try. The reviewers are meticulous in their feedback and the issues can be easily addressed.
(0) 讚! | xuesejieran

作者: 无人区玫瑰


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-16 09:08:35 評論於
Christel Bergström, it has been a month.
(0) 讚! | 无人区玫瑰

作者: 斯可力


領域: 医学
審稿時間: 7.0 month(s)
結果: 修改後接受


撰寫評論

2024-10-15 10:47:45 評論於
Submitted in March 2024
Accepted on October 3, 2024
After 3 rounds of revisions and 2 additional experiments, it took approximately 7 months.
Some of the reviewer's comments were helpful in improving the quality of the article. However, the completeness of the experiments was still lacking at the time of acceptance. The editor and reviewers may have been lenient due to the innovative nature of the research.
(0) 讚! | 斯可力

作者: hongbucuo


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2024-10-15 08:30:11 評論於
Which editor?
(0) 讚! | hongbucuo

作者: 无人区玫瑰


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-14 09:47:12 評論於
Submitted on September 7, 2024, it has been a week since it was assigned to the deputy editor, and it has been almost a month but still hasn't been sent for review. Why is that?
(0) 讚! | 无人区玫瑰

作者: 白骨啸天


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-30 23:18:20 評論於
5.30 accept, thank my little mol for being perfect, the efficiency of editors and reviewers is super high, gratitude and gratitude
(0) 讚! | 白骨啸天

作者: yetom


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-04-20 10:44:50 評論於
I am very grateful to receive it. Although the external review took two months and was a bit slow, the reviewers gave very good suggestions. After making revisions for over a month, it was quickly accepted within a week. The editor has a great attitude and works quickly. Thumbs up. It is a well-respected magazine, I hope the score could be a bit higher
(0) 讚! | yetom

作者: 晨风杉月


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-18 22:17:34 評論於
I submitted for external review on March 18th, and it has been a month but the results of the external review have not yet been released
(0) 讚! | 晨风杉月

作者: 晨风杉月


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-18 20:52:40 評論於
It's been a month and I still haven't received the review results
(0) 讚! | 晨风杉月

作者: 白骨啸天


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-18 20:13:05 評論於
It should be soon, please be patient and everything will go smoothly
(0) 讚! | 白骨啸天

作者: 宗室永亮


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-18 18:09:53 評論於
Congratulations! It has been almost a month and I am still editing here, not sure what to do
(0) 讚! | 宗室永亮

作者: 白骨啸天


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-18 10:42:37 評論於
Good luck!
(0) 讚! | 白骨啸天

作者: 宗室永亮


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-18 08:34:50 評論於
Just wait after I submit it, I have been editing here for a month
(0) 讚! | 宗室永亮

作者: 白骨啸天


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-17 08:29:28 評論於
Thank you to the kind-hearted reviewers and editors for their efficient work. Peer review began on April 2nd, and we received revision suggestions on April 15th. There were a total of three reviewers, with the first suggesting minor revisions and the other two suggesting reconsideration after major revisions. The third reviewer is very thorough and attentive, and we are currently working on revisions. We hope for acceptance and will continue to work hard
(0) 讚! | 白骨啸天

作者: 宗室永亮


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-03 20:21:40 評論於
Have you received any news?
(0) 讚! | 宗室永亮

作者: 宗室永亮


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-03 15:12:08 評論於
Similarly, it has always been under review
(0) 讚! | 宗室永亮

作者: 宗室永亮


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-03 08:55:29 評論於
Same question, it has been under review for a long time, I don't know if it has been sent for external review
(0) 讚! | 宗室永亮

作者: 宗室永亮


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-01 11:14:02 評論於
Status is sent to the deputy editor, how long does it usually take to get reviewed externally? Submitted on 3.25
(0) 讚! | 宗室永亮

作者: 白骨啸天


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-26 17:18:41 評論於
Review speed: 3.0 | Submission hit rate: 50.0
Research focus: peptide
Sharing experience: 
Specific situation: Submitted on 3.28, AE assigned on the same day. 
Sharing a little experience for good luck: On the submission page, it showed as "under review" right after submission. By clicking on "instructions & forms" in the top right corner, more detailed submission status can be seen. On 4.2, suddenly saw the status change to "In peer review".
Lastly, making a wish: Hope to receive minor revisions and get accepted next month
(0) 讚! | 白骨啸天

作者: 浅时光


領域: 医学
審稿時間: 4.0 month(s)
結果: 拒稿


撰寫評論

2024-03-10 20:34:50 評論於
There are four reviewers, with two providing professional feedback and the other two offering seemingly nonsensical comments without carefully reading the article. After a major revision following the first review, the submission was ultimately rejected more than a month later. It was a waste of over four months
(0) 讚! | 浅时光

作者: 五郎嘉悦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-14 23:33:21 評論於
How do I see what has been edited all along?
(0) 讚! | 五郎嘉悦

作者: 金山萱彤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-26 14:13:45 評論於
I've been editing there and haven't submitted it for review, it's been almost a month
(0) 讚! | 金山萱彤

作者: Monroe Kipling


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-15 13:35:54 評論於
Is the submission system very unique? It feels like a phishing website, submitted but always under editing unallocated, what is the reason?
(0) 讚! | Monroe Kipling

作者: 五河千易


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-27 20:25:42 評論於
Hello, have you received any news yet? Mine also went under review on the second day, but they didn't mention any assigned editor
(0) 讚! | 五河千易

作者: 坠星智越


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-14 22:09:57 評論於
Same question, it's been nearly twenty days for me, and the interface is still under review, just like it was right after I submitted
(0) 讚! | 坠星智越

首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)

開始撰寫 [MOLECULAR PHARMACEUTICS] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*